Agenus reported $18.99M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Agenus AGEN:US $ 18.99M 17.71M
Amgen AMGN:US $ 5327M 250M
AstraZeneca AZN:LN 9.61B 562M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Celldex Therapeutics CLDX:US $ 0.1M 0.15M
Chemocentryx CCXI:US $ 4.95M 2.14M
CSL CSL:AU $ 2.31B 518.2M
Dynavax Technologies DVAX:US $ 174.24M 37.31M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Gilead Sciences GILD:US $ 4118M 331M
Glaxosmithkline GSK:US $ 6870M 1927M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Intrexon XON:US $ 0.56M 24.3M
Jiangsu Hengrui Me. 600276:CH CH 8.31B 652.19M
Karyopharm Therapeutics KPTI:US $ 23.48M 1.51M
Macrogenics MGNX:US $ 18.38M 3.48M
Merck MRK:GR € 4867M 162M
Novartis NOVN:VX 8.91B 232M
Novavax NVAX:US $ 194.53M 283.62M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Rigel Pharmaceuticals RIGL:US $ 17.2M 1.96M
Sangamo Biosciences SGMO:US $ 6.29M 1M
Veracyte VCYT:US $ 40.45M 2.03M
YTE INCY:US $ 682.97M 120.62M